Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro.
Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro.
复制标题
DOI:
10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
复制
发表时间:
2016-07-05
期刊:
影响因子:
--
通讯作者:
Christofferson, Rebecca C
中科院分区:
文献类型:
--
作者:
Charles, Anu Susan;Christofferson, Rebecca C
INTRODUCTION: Zika virus (ZIKV) has emerged in dengue (DENV) endemic areas, where these two related flaviviruses continue to co-circulate. DENV is a complex of four serotypes and infections can progress to severe disease. It is thought that this is mediated by antibody dependent enhancement (ADE) whereby antibodies from a primary DENV infection are incapable of neutralizing heterologous DENV infections with another serotype. ADE has been demonstrated among other members of the Flavivirus group.METHODS: We utilize an in vitro ADE assay developed for DENV to determine whether ZIKV is enhanced by a commonly available DENV serotype 2-derived monoclonal antibody (4G2).RESULTS: We show that ZIKV infection in vitro is enhanced in the presence of the 4G2 mAb.DISCUSSION: Our results demonstrate that ADE between ZIKV and DENV is possible and that the 4G2 antibody is a useful tool for the effects of pre-existing anti-DENV antibodies during ZIKV infections.